6
Participants
Start Date
January 4, 2021
Primary Completion Date
January 10, 2024
Study Completion Date
January 10, 2024
Erenumab
a CGRP receptor monoclonal antibody
Placebo
Placebo
Mayo Clinic, Jacksonville
Mayo Clinic, Rochester
Phoenix VA Health Care System, Phoenix
Mayo Clinic, Phoenix
Mayo Clinic in Arizona, Scottsdale
Lead Sponsor
Collaborators (1)
University of Arizona
OTHER
Translational Genomics Research Institute
OTHER
Arizona State University
OTHER
Phoenix VA Health Care System
FED
United States Department of Defense
FED
Amgen
INDUSTRY
Georgia Institute of Technology
OTHER
Mayo Clinic
OTHER